Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Faham
Improved Survival With T Cell Clonotype Stability After Anti-Ctla-4 Treatment in Cancer Patients
Science Translational Medicine
Medicine
High-Throughput, High-Accuracy Array-Based Resequencing
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Dose-Dependent Effect of Anti-Ctla-4 on Survival in Sepsis
Shock
Critical Care
Emergency Medicine
Intensive Care Medicine
Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’
British Journal of Cancer
Cancer Research
Oncology
Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients With Small Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated With Anti-Ctla-4 Antibodies: Association With Overall Survival?
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Expression of CTLA-4 and Foxp3 in Peripheral Blood T Cells of Patients With Squamous Cell Laryngeal Carcinoma
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate With Poor Prognosis
Cancer Research
Cancer Research
Oncology
T-Cell Landscape in a Primary Melanoma Predicts the Survival of Patients With Metastatic Disease After Their Treatment With Dendritic Cell Vaccines
Cancer Research
Cancer Research
Oncology
CTLA-4 Antibody Ipilimumab Negatively Affects CD4+ T-Cell Responses in Vitro
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells From Patients With Breast Cancer
Asian Pacific Journal of Cancer Prevention
